Insufficient control of blood pressure (BP) in hypertension continues to represent an unmet need of contemporary medicine. In a recent analysis performed by the NCD-RisC (non-communicable diseases Risk Factor Collaboration), BP control ranged from about 15% to 60%.1 In addition, a cross-sectional analysis of National Health and Nutrition Examination Survey showed that the proportion of patients with controlled BP has even declined to 43.7% in the most recent timeframe (2017–2018).

Novel ANP (Atrial Natriuretic Peptide) based therapy for hypertension: the promising role of a disease mechanism targeted approach / Volpe, Massimo; Gallo, Giovanna; Rubattu, Speranza. - In: HYPERTENSION. - ISSN 0194-911X. - 78:6(2021), pp. 1868-1870. [10.1161/HYPERTENSIONAHA.121.18264]

Novel ANP (Atrial Natriuretic Peptide) based therapy for hypertension: the promising role of a disease mechanism targeted approach

Volpe, Massimo
Conceptualization
;
Gallo, Giovanna
Investigation
;
Rubattu, Speranza
Conceptualization
2021

Abstract

Insufficient control of blood pressure (BP) in hypertension continues to represent an unmet need of contemporary medicine. In a recent analysis performed by the NCD-RisC (non-communicable diseases Risk Factor Collaboration), BP control ranged from about 15% to 60%.1 In addition, a cross-sectional analysis of National Health and Nutrition Examination Survey showed that the proportion of patients with controlled BP has even declined to 43.7% in the most recent timeframe (2017–2018).
2021
atrial natriuretic peptide; hypertension; anti-hypertensive therapy; MANP
01 Pubblicazione su rivista::01m Editorial/Introduzione in rivista
Novel ANP (Atrial Natriuretic Peptide) based therapy for hypertension: the promising role of a disease mechanism targeted approach / Volpe, Massimo; Gallo, Giovanna; Rubattu, Speranza. - In: HYPERTENSION. - ISSN 0194-911X. - 78:6(2021), pp. 1868-1870. [10.1161/HYPERTENSIONAHA.121.18264]
File allegati a questo prodotto
File Dimensione Formato  
Volpe_Novel-ANP_2021.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 222.58 kB
Formato Adobe PDF
222.58 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1585141
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 9
social impact